Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Powder discontinued extensively hydrolysed formula (0913351)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nutramigen 1 LIPIL powder
0913351A0BBAAAA
|
Nutramigen powder disc extensively hydrolysed formula | Powder discontinued extensively hydrolysed formula (0913351) | Nutrition and Blood | 1 |
|
Generic Nutramigen 1 LIPIL powder
0913351A0AAAAAA
|
Powder discontinued extensively hydrolysed formula (0913351) | Powder discontinued extensively hydrolysed formula (0913351) | Nutrition and Blood | No data available |
|
Generic Nutramigen 2 LIPIL powder
0913351A0AAABAB
|
Powder discontinued extensively hydrolysed formula (0913351) | Powder discontinued extensively hydrolysed formula (0913351) | Nutrition and Blood | No data available |
|
Nutramigen 2 LIPIL powder
0913351A0BBABAB
|
Nutramigen powder disc extensively hydrolysed formula | Powder discontinued extensively hydrolysed formula (0913351) | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.